Cargando…
Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials
INTRODUCTION: Patient-reported outcome (PRO) measures serve to capture vital patient information not otherwise obtained by primary study endpoints. This paper examines how PROs are utilized as endpoints in industry-sponsored metastatic breast cancer clinical trials. METHODS: A search was conducted i...
Autores principales: | Krohe, Meaghan, Hao, Yanni, Lamoureux, Roger E., Galipeau, Nina, Globe, Denise, Foley, Catherine, Mazar, Iyar, Solomon, Jeffrey, Shields, Alan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946584/ https://www.ncbi.nlm.nih.gov/pubmed/27441001 http://dx.doi.org/10.4137/BCBCR.S39385 |
Ejemplares similares
-
Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature
por: Eek, Daniel, et al.
Publicado: (2016) -
Content validity of the National Comprehensive Cancer Network – Functional Assessment of Cancer Therapy – Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients
por: Krohe, Meaghan, et al.
Publicado: (2019) -
Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
por: Galipeau, Nina, et al.
Publicado: (2019) -
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF(©)
por: Taylor, Fiona, et al.
Publicado: (2021) -
Industry - from sponsor to provider?
por: Griebenow, Reinhard
Publicado: (2017)